1813 Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer. (September 2015) - Kotoula, V.; Zagouri, F.; Alexopoulou, Z.; Gogas, H.; Lakis, S.; Pentheroudakis, G.; Bobos, M.; Papadopoulou, K.; Tsolaki, E.; Skondra, M.; Karavasilis, V.; Koutras, A.; et al.